| Publicerad idag 09:13

Annexin Pharmaceuticals | Investing in Life Science 2026

SPONSRAT INNEHÅLL | [email protected]

CEO Anders Haegerstrand presents Annexin Pharmaceuticals at Investing in Life Science 2026.

The content of BioStock’s news and analysis is independent, but BioStock’s operations are to some extent financed by companies in the industry. This post refers to a company from which BioStock has received funding.